Fennec Q2 revenue $3.3M (up 98% QoQ); appoints Adrian Haigh as COO

FENNEC PHARMACEUTICALS INC.

2023-Q2 EPS reported -$0.43 revenue$5,002,000

Net product sales of $3.3M for Q2 2023, up 98% from Q1 2023; gross profit $3.2M.
Net loss of $5.4M ($0.21 diluted EPS) vs $5.1M loss ($0.19) in Q2 2022.
Cash and equivalents $15.0M; sufficient to fund operations for at least 12 months.
Adrian Haigh appointed COO, stepping down from board; base salary €400K/yr plus bonus and 200K options.
Management to present at 2023 Wedbush PacGrow Healthcare Conference on August 8-9.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Adrian Haigh

Chief Commercial Officer

FENC · FENNEC PHARMACEUTICALS INC.

Effective: 2023-08-03
Filed: August 4, 2023, 7:59 PM ET

In the same press release it was announced that Mr. Haigh had accepted the appointment as Chief Commercial Officer.

Departed

Adrian Haigh

Director

FENC · FENNEC PHARMACEUTICALS INC.

Effective: 2023-08-03
Filed: August 4, 2023, 7:59 PM ET

Adrian Haigh had stepped down from the the position of Director of Fennec Pharmaceuticals Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Adrian Haigh was appointed as Chief Commercial Officer at FENNEC PHARMACEUTICALS INC..

Action: appointed
Role: Chief Commercial Officer

Exact text from the filing

In the same press release it was announced that Mr. Haigh had accepted the appointment as Chief Commercial Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Adrian Haigh departed as Director at FENNEC PHARMACEUTICALS INC..

Action: stepped down
Role: Director

Exact text from the filing

Adrian Haigh had stepped down from the the position of Director of Fennec Pharmaceuticals Inc.

View on SEC.gov

FENNEC PHARMACEUTICALS INC. filing history →

Source: SEC EDGAR

accession 0001104659-23-087631

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.